Form 4: Precigen COO Rutul R. Shah Reports Stock Transactions

Rutul R. Shah, Chief Operating Officer of Precigen, Inc., reports the acquisition and disposal of common stock and restricted stock units on April 5, 2024.

Summary

• On April 5, 2024, Rutul R. Shah, the Chief Operating Officer of Precigen, Inc., engaged in transactions involving the company's stock.
• Shah acquired 117,142 shares of common stock through the vesting of restricted stock units (RSUs).
• Simultaneously, Shah disposed of 117,142 shares of common stock related to the RSU vesting.
• Additionally, 40,870 shares were disposed of to cover income tax withholding obligations at a price of $1.4 per share.
• Following these transactions, Shah directly owns 209,746 shares of Precigen common stock and 0 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading activities.
• Similar filings are expected from executives at comparable biotechnology companies like Intrexon (now Precigen) and other gene and cell therapy companies.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily reflect the vesting of previously granted compensation.
• The disposal of shares for tax obligations is a standard procedure and doesn't signal any change in the executive's confidence in the company.

Key Dates